Research
A new type of CAR-T cell therapy is targeted to B-cell blood cancers that have returned and no longer respond to other treatments.
Latest stories
Biotherapeutics
May 26, 2023
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community